TheScientist reviews 2009

TheScientist present their 2009 in review (+as a PDF file) an interesting and eventful year!

It's hard to pick the most significant event, but it might well be the first; in January the FDA approved the first-ever clinical trial of a human embryonic stem cell-based therapy.  (They subsequently held it in August, but still.)  Then in February the U.S. Congress approved the $789B recovery bill, including a number of provisions for improving health care and grants to the NIH and NSF.  Wow.

And who knows what 2010 will bring? 

(my vote would be - ever increasing adoption of digital pathology :)